[Therapy of spondylitis ankylopoetica with levamisole. Behavior of clinical and immunological parameters].
The therapeutical effect of levamisole in ankylosing spondylitis as well as the effect of this therapy on the immunologic parameters were to be examined. Since the sample consisted of 10 patients only, statistically relevant results were not to be expected. Only male patients with positive HLA-B 27 have been examined. The therapeutical effect after treatment of 3 months has been observed as good to very good. The immunologic parameters reacted in a mode which had formerly been described as immunomodulating.
D000328:Adult; D000368:Aged; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000276:immunology
D007978:Levamisole
Therapie der Spondylitis ankylopoetica mit Levamisole. Verhalten klinischer und immunologischer Parameter.